NSAID Use By COVID Patients Not Associated With Adverse Outcomes Or Mortality – Danish Study
Study of almost 10,000 COVID-19 patients finds use of ibuprofen and other NSAIDs does not increase chance of being hospitalized, admitted to the intensive care unit, or dying.
You may also be interested in...
Rx-to-OTC switches of the painkillers dexibuprofen and single-pill combinations of ibuprofen and paracetamol as well as the cough medicine levodropropizine, all for oral use, will be considered at the next German Expert Committee for Prescription meeting on 13 July.
French advertisements for OTC drugs that treat symptoms which could be associated with COVID-19 are set to carry new warning statements following a recommendation by the country's medicines regulator.
Review by MHRA advisory body finds no issue with ibuprofen use in COVID-19 patients and updates advice to recommend either paracetamol or ibuprofen to treat symptoms.